# Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib

> **NCT01070706** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jungsil Ro** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Paclitaxel,Gemcitabine,Sunitinib

## Key facts

- **NCT ID:** NCT01070706
- **Lead sponsor:** Jungsil Ro
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2010-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070706, "Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01070706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*